[ad_1]
SAN FRANCISCO , June 28, 2022 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled “Immunohistochemistry – Global Market Trajectory & Analytics”. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE
What’s New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to our digital archives and MarketGlass Research Platform
- Complimentary updates for one year
Edition: 6; Released: January 2022 Full story available on Benzinga.com [ad_2]
Executive Pool: 2848
Companies: 31 – Players covered include Abcam PLC; Agilent Technologies, Inc.; Bio Sb, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; MilliporeSigma; PerkinElmer, Inc.; Thermo Fisher Scientific, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Application (Diagnostics, Drug Testing); Product (Antibodies, Reagents, Kits, Equipment)
Geographies: World; United States; Canada; Japan; China; Europe (France;
Source link
